Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2014 19:29 ET | Source: MannKind

MannKind Announces Receipt of $150 Million Licensing Upfront Payment

VALENCIA, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that it had received a $150 million upfront payment in connection with an exclusive worldwide...
September 24, 2014 17:00 ET | Source: MannKind

MannKind Announces Closing of Global Licensing Agreement With Sanofi

VALENCIA, Calif., Sept. 24, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced the closing of a worldwide exclusive collaboration and licensing agreement with Sanofi for...
September 02, 2014 17:00 ET | Source: MannKind

MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference

VALENCIA, Calif., Sept. 2, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that...
August 11, 2014 09:00 ET | Source: MannKind

MannKind Corporation Reports 2014 Second Quarter Financial Results

VALENCIA, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the second quarter ended June 30, 2014. For the second quarter of 2014,...
August 05, 2014 17:00 ET | Source: MannKind

MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014

VALENCIA, Calif., Aug. 5, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2014 second quarter financial results on Monday, August 11, 2014 and its management will host a...
June 27, 2014 17:06 ET | Source: MannKind

MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes

VALENCIA, Calif., June 27, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that the U.S. Food & Drug Administration (FDA) has approved AFREZZA® (insulin human)...
May 27, 2014 09:00 ET | Source: MannKind

MannKind to Present at Upcoming Conferences

VALENCIA, Calif., May 27, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will...
May 12, 2014 09:00 ET | Source: MannKind

MannKind Corporation Reports 2014 First Quarter Financial Results

VALENCIA, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the first quarter ended March 31, 2014. For the first quarter of 2014,...
May 07, 2014 17:00 ET | Source: MannKind

MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference

VALENCIA, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will...
May 05, 2014 09:00 ET | Source: MannKind

MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014

VALENCIA, Calif., May 5, 2014 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2014 first quarter financial results on Monday, May 12, 2014 and its management will host a...